Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1949 of 6351
-
New cancer drug TORL-1-23 enters first human tests
Disease control Recruiting nowThis first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-1-23 in patients with advanced cancer
Phase 1 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New shot shows promise for long-term platelet control in rare bleeding disorder
Disease control OngoingA Phase 3 study to evaluate the safety and efficacy of efgartigimod PH20 subcutaneous in adult patients with primary immune thrombocytopenia
Phase 3 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for FSGS? obinutuzumab trial targets tough cases
Disease control CompletedThe purpose of this study is to evaluate the safety and efficacy of Obinutuzumab in inducing complete or partial remission of proteinuria.
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New radiation method aims to shield brain function during cancer treatment
Disease control Recruiting nowStudy patients will receive Whole-brain radiation therapy (WBRT) - pulsed reduced dose rate (PRDR) within 14 days of registration. All patients will receive single daily fractions using 3D conformal radiotherapy. A dose of 30 Gy in 10 fractions will be delivered using the PRDR te…
Phase 2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a radioactive tracer reveal hidden lung scarring?
Knowledge-focused OngoingThis is a prospective exploratory biodistribution study in patients with interstitial lung disease (ILD). The purpose of this research study is to determine where and to which degree the FAPI tracer (68Ga-FAPI-46) accumulates in normal and fibrotic lung tissues of patients with …
Early phase 1 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Balloon vs stent: new hope for heart patients without permanent metal?
Disease control OngoingInternational, multicentric, prospective, investigator-driven, open-label, randomized (1:1) clinical trial to observe and evaluate the efficacy, of Magic Touch Sirolimus Coated Balloon (SCB) compared to one of the gold standard treatment for native vessel disease (everolimus-elut…
Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Could laughing gas lift depression in seniors?
Symptom relief CompletedResistant Depression is a common condition in older adults and there is an urgent need for novel antidepressant in this population. Nitrous Oxide (N2O) has recently shown rapid antidepressant effect in midlife depression but no study has currently investigated the efficacy and sa…
Sponsor: University Hospital, Tours • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New drug may tame Life-Threatening side effects of cancer immunotherapy
Disease control CompletedThis study will evaluate the use of siltuximab to decrease the severity of cytokine release syndrome (CRS) and immune effector cell-associated neurological syndrome (ICANS) in patients who will receive chimeric antigen receptor (CAR) T-cell therapy for the treatment of hematologi…
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
HIV-Positive kidneys for HIV-Positive patients: a lifesaving match?
Disease control Recruiting nowThe U.S. Department of Health and Human Services (HHS), through the National Institutes of Health (NIH), published Final Human Immunodeficiency Virus (HIV) Organ Policy Equity (HOPE) Act Safeguards and Research Criteria for Transplantation of Organs Infected With HIV. All such tr…
Sponsor: Tulane University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can schools and doctors together boost HPV shots in teens?
Vaccine CompletedThis study aims at evaluating the effectiveness, efficiency and implementation of a multicomponent intervention (components being applied in combination or alone) on the acceptability of HPV vaccine among French adolescents (11-14 years old) through a cluster randomized controlle…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Vaccine
Last updated Jun 27, 2026 08:03 UTC
-
New drug combo targets tough adrenal cancer
Disease control Ongoing* Clinical Indication : Advanced adrenal cortical carcinoma after platinum-based chemotherapy * Trial Type : Single arm, prospective trial * Route of administration : Intravenous (pembrolizumab) and peroral (lenvatinib) * Treatment Groups : Single arm * Number of trial participan…
Phase 2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New program aims to keep seniors strong and independent longer
Prevention CompletedFrailty is a geriatric syndrome characterized by a decrease in the function of various organs and systems that leads to a greater risk of suffering from diseases or disabilities. Frailty is usually accompanied by weight loss, loss of strength, slowing of walking speed, fatigue an…
Sponsor: Consorci Sanitari del Maresme • Aim: Prevention
Last updated Jun 27, 2026 12:01 UTC
-
Three extra minutes on an MRI could catch a deadly side effect of cancer treatment
Diagnosis OngoingAnti-cancer immunotherapy, one of the therapeutic revolutions of recent years. It is based on the use of antibodies that block immune system checkpoints that have been hijacked by cancer cells to benefit themselves. Blocking these checkpoints, such as PD-1, unleashes the action o…
Sponsor: Centre Chirurgical Marie Lannelongue • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Smaller incisions, big hopes: new surgery for stomach cancer under trial
Disease control OngoingThe aim of this study is to verify the safety and efficacy of single or reduced ports laparoscopic gastrectomy for advanced gastric cancer.
Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could a Home-Based exercise and relaxation program tame diabetes and Post-COVID stress?
Disease control CompletedType-2 Diabetes Mellitus (DM) disease, like other chronic diseases, is a group of diseases that are adversely affected by the COVID-19 pandemic.This study was planned to examine the effect of COVID-19 disease on patients with Type-2 DM and to investigate the effects of progressiv…
Sponsor: Bozyaka Training and Research Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New blood test could save lives in liver failure bleeding emergencies
Disease control CompletedIn this project, we plan to evaluate whether a new, rotational thromboelastometry-guided algorithm (ROTEM) to guide hemostatic resuscitation decreases the use of allogeneic blood products, the total amount of bleeding, transfusion related side effects, thromboembolic complication…
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Double radiation attack shows promise for returning prostate cancer
Disease control CompletedParticipants will either receive treatment with standard SBRT and the study drug Radium (Ra-223) dichloride, or standard SBRT alone.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New combo therapy hopes to tame advanced cancers
Disease control OngoingThis is an investigator-initiated industry-supported phase 1 clinical trial conducted in the phase 1 clinic at The University of Texas MD Anderson Cancer Center who will hold the Investigational New Drug (IND). Lvygen Biopharma will provide as investigational supply LVGN3616, LVG…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New study aims to cut opioid use in transgender surgery recovery
Symptom relief Recruiting nowThis study will compare the current standard-of-care pain treatment regimen options that are available to patients who undergo gender-affirming surgery. The purpose of this research is to determine if any of these options are more (versus less) effective than the others to manage…
Phase 3 • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 26, 2026 17:38 UTC
-
Bringing the gym to the farm: could a tailored home workout beat cancer fatigue?
Symptom relief OngoingThe objective of this investigation is to establish the feasibility and initial effectiveness of a novel exercise program for rural cancer survivors in Colorado suffering from cancer related fatigue. Participation in an exercise program has regularly been shown to reduce fatigue …
Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC